Live Breaking News & Updates on Bipolari Disorder Who Are Early

Stay updated with breaking news from Bipolari disorder who are early. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alkermes plc: Alkermes Showcases Research from Psychiatry Portfolio at Psych Congress

? Clinical, Epidemiology and Health Economics and Outcomes Research Shared at Key Psychiatry Conference ? DUBLIN, Sept. 20, 2022 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced ....

United States , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Sandy Coombs , Psych Congress , Wellness Survey Data , Research Development At Alkermes , Analysis Of National Health , Outcomes Research Shared At Key Psychiatry Conference , Health Economics , Alkermes Inc , Alkermes Pharma Ireland , Outcomes Research Shared , Key Psychiatry Conference , Chief Medical Officer , Executive Vice President , Young Adults , Schizophreniform Disorder , Bipolari Disorder Who Are Early , Study Design , Interim Demographics , Long Term Safety , Symptom Trajectory , Female Patients , Post Hoc ,

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International. ....

New York , United States , Alex Braun , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Behavioral Health System , Research Databases , Schizophrenia International Research Society , Research Development At Alkermes , Department Of Psychiatry , Icahn School Of Medicine At Mount Sinai , Alkermes Inc , Alkermes Pharma Ireland , Detailed Results Presented From , Early Phase , Patients Early , New York Assessment , Adverse Cognitive Effects , Neuropsychiatric Treatment , Chief Medical Officer , Executive Vice President , Young Adults , Schizophreniform Disorder , Bipolari Disorder Who Are Early , Their Illness ,

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented ....

New York , United States , Alex Braun , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Behavioral Health System , Research Databases , Schizophrenia International Research Society , Research Development At Alkermes , Department Of Psychiatry , Icahn School Of Medicine At Mount Sinai , Alkermes Inc , Alkermes Pharma Ireland , Results Presented From , Early Phase , Patients Early , New York Assessment , Adverse Cognitive Effects , Neuropsychiatric Treatment , Chief Medical Officer , Executive Vice President , Young Adults , Schizophreniform Disorder , Bipolari Disorder Who Are Early , Their Illness ,